Common questions about Respo (FAQ)
Q: If I miss a dose of Respo, what am I supposed to do?
Official labeling describes that if a dose is missed, it can be taken when remembered. However, if it is close to the time for the next scheduled dose, the regulatory information indicates skipping the missed dose and continuing with the regular schedule. Taking a double dose is not recommended by the manufacturer.
Q: How long does it usually take to feel the main effect of Respo?
Studies and official information indicate that Respo typically begins to show an effect after approximately four to six weeks of starting treatment. The full benefits of the medicine may continue to increase and improve for up to about six months after initiating therapy. This time lag is expected because the medicine works by slowly modifying the underlying disease process.
Q: How long does Respo stay in your system after stopping it?
The active substance in Respo has a very long half-life; this means it takes a substantial time for the compound to leave the body. Its concentration may remain in the bloodstream for up to one to four weeks, and in some cases, it can take up to two years for the levels to become undetectable without an official drug elimination procedure. This persistence is why a 'washout' procedure may be described upon discontinuation.
Q: Are the initial side effects of Respo temporary?
Many of the commonly reported side effects, such as diarrhea, nausea, and headache, are described in official sources as often being mild and temporary. These initial effects typically subside within a few days or weeks as the body adjusts to the medicine. If side effects become persistent, severe, or difficult to tolerate, it is necessary to discuss these concerns with a healthcare professional.
Q: Is there a generic version of Respo available yet?
Yes, the active ingredient contained in Respo is leflunomide, which is approved by regulatory agencies and is available as an official generic tablet formulation.
Q: Are the side effects of Respo permanent?
While most side effects resolve after stopping the medicine, official warnings note that some rare but severe documented effects, such as liver damage or peripheral neuropathy (nerve problems), may be persistent in some individuals. However, the majority of patients who experience peripheral neuropathy recover after discontinuing the medicine.
Q: What should I do if Respo makes me feel nauseous?
Nausea is listed in official product information as a Very Common side effect. Since specific management advice is not provided in the regulatory labeling, any persistent or severe nausea, or nausea that occurs alongside other symptoms of liver toxicity, should be discussed with a healthcare professional.
Q: Does Respo affect the effectiveness of birth control pills?
Official drug interaction information describes the active metabolite of Respo as having the potential to increase the systemic exposure of certain co-administered medicines that are substrates for specific transporters, including oral contraceptives. Regulatory documents state caution is advised when these medicines are used together.
Q: Is Respo safe to use before surgery?
Due to the medicine's long half-life, an accelerated drug elimination procedure (often called a washout) is sometimes described as a recommended action if treatment is stopped prior to an anticipated surgical procedure. This procedure helps reduce the concentration of the medicine in the body before the operation.
Q: Can Respo be taken with just water, or is food needed?
The film-coated tablet should be swallowed whole with water, and the official administration protocol states that it can be taken with or without food. Consistency in taking the medicine according to the prescribed daily schedule is considered an expectation.
Q: Is there any specific food or drink to avoid when using Respo?
Official regulatory documents state that alcohol consumption is not recommended during treatment with Respo. This is due to the potential for an increased risk of severe liver injury when alcohol and this medicine are used together.
Q: Is Respo known to cause weight gain?
Official reports on adverse events do not list weight gain as a commonly documented or serious side effect of the medicine. However, official information does note that weight loss and anorexia (loss of appetite) are listed as less common side effects.
Q: Can older adults safely use Respo?
Studies reviewed by regulatory agencies have not demonstrated specific problems that would strictly limit the usefulness of Respo in older adults. However, it is noted that older patients may have an increased likelihood of age-related nerve problems, which is a consideration, as peripheral neuropathy has been reported as a side effect.
Q: Are there different forms of Respo available (e.g., tablet, liquid)?
Respo is officially supplied and approved as a film-coated tablet in various strengths. Regulatory information does not list an approved liquid or other dosage forms.
Q: Can Respo cause problems with sleep?
Official adverse event listings do not explicitly name sleep problems or insomnia as a common or serious adverse reaction of Respo. However, reported side effects such as headache, dizziness, and nerve issues could potentially have an indirect effect on sleep.
Q: What are the chances of a serious side effect from Respo?
Official product information classifies serious side effects, such as severe liver injury, severe skin reactions, and lung disease, as either rare or very rare. This classification means that these events are documented to occur in less than 1 in 100 people or even less than 1 in 1,000 people in clinical data.
Q: Do you have to take Respo at the same time every day?
The medicine is approved for a straightforward once-daily dosing schedule. A consistent daily schedule is an expected standard for maintaining stable therapeutic levels of long-acting medicines.
Q: How do the benefits of Respo outweigh its known risks?
Regulatory bodies grant marketing authorization when the evidence demonstrates that the benefit is determined to outweigh the identified risks for the approved patient population. Studies have shown the medicine to be effective in reducing the signs, symptoms, and progression of joint damage associated with conditions like rheumatoid arthritis.
Q: What is the half-life of Respo?
The active substance in Respo has a long half-life, meaning the time it takes for half of the dose to be eliminated from the body is extensive. This half-life is typically documented by regulatory bodies as being approximately 2 to 3 weeks (or 1 to 4 weeks).
Q: Has Respo received a black box warning?
Yes, Respo includes a Boxed Warning in the US prescribing information for the potential risks of severe Hepatotoxicity (liver injury) and Embryo-Fetal Toxicity. The Boxed Warning is the formal regulatory term for what is commonly referred to by users as a 'black box warning'.
Q: What happens if Respo stops working for me after a while?
Treatment with Respo is managed under the supervision of a specialist. Patient management guidelines describe that a specialist may determine whether adjusting the dose or discontinuing the treatment is appropriate. If treatment is stopped, a washout procedure may be necessary due to the long duration the drug remains in the system.
Q: Is there a test to see if Respo is right for me?
While there is no single predictive test to determine individual suitability, official labeling requires mandatory pre-treatment screening before starting the medicine. This screening includes a pregnancy test for women of childbearing potential, blood pressure checks, and laboratory tests (such as liver enzyme and blood counts) to ensure appropriate baseline health.
